Skip to main content
. 2022 Nov 24;12:1044328. doi: 10.3389/fonc.2022.1044328

Figure 1.

Figure 1

Progression free survival of fruquintinib vs. other TKIs group. FRI, Fruquintinib; HR, Hazard ratio; PFS, progression free survival; TKI, tyrosine kinase inhibitor. * P-value in Cox regression model. p < 0.05 considered statistically significant.